IBDEI331 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,49218,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49218,1,3,0)
 ;;=3^Secondary Malig Neop Cerebral Meninges
 ;;^UTILITY(U,$J,358.3,49218,1,4,0)
 ;;=4^C79.32
 ;;^UTILITY(U,$J,358.3,49218,2)
 ;;=^5001348
 ;;^UTILITY(U,$J,358.3,49219,0)
 ;;=G89.3^^187^2437^30
 ;;^UTILITY(U,$J,358.3,49219,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49219,1,3,0)
 ;;=3^Neoplasm Related Pain
 ;;^UTILITY(U,$J,358.3,49219,1,4,0)
 ;;=4^G89.3
 ;;^UTILITY(U,$J,358.3,49219,2)
 ;;=^5004159
 ;;^UTILITY(U,$J,358.3,49220,0)
 ;;=C79.82^^187^2437^36
 ;;^UTILITY(U,$J,358.3,49220,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49220,1,3,0)
 ;;=3^Secondary Malig Neop Genital Organs
 ;;^UTILITY(U,$J,358.3,49220,1,4,0)
 ;;=4^C79.82
 ;;^UTILITY(U,$J,358.3,49220,2)
 ;;=^267339
 ;;^UTILITY(U,$J,358.3,49221,0)
 ;;=C49.A2^^187^2437^1
 ;;^UTILITY(U,$J,358.3,49221,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49221,1,3,0)
 ;;=3^GIST,Stomach
 ;;^UTILITY(U,$J,358.3,49221,1,4,0)
 ;;=4^C49.A2
 ;;^UTILITY(U,$J,358.3,49221,2)
 ;;=^8148063
 ;;^UTILITY(U,$J,358.3,49222,0)
 ;;=I50.9^^187^2438^16
 ;;^UTILITY(U,$J,358.3,49222,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49222,1,3,0)
 ;;=3^Heart Failure,Unsp
 ;;^UTILITY(U,$J,358.3,49222,1,4,0)
 ;;=4^I50.9
 ;;^UTILITY(U,$J,358.3,49222,2)
 ;;=^5007251
 ;;^UTILITY(U,$J,358.3,49223,0)
 ;;=I73.9^^187^2438^22
 ;;^UTILITY(U,$J,358.3,49223,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49223,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,49223,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,49223,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,49224,0)
 ;;=I35.0^^187^2438^20
 ;;^UTILITY(U,$J,358.3,49224,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49224,1,3,0)
 ;;=3^Nonrheumatic Aortic Vlve Stenosis
 ;;^UTILITY(U,$J,358.3,49224,1,4,0)
 ;;=4^I35.0
 ;;^UTILITY(U,$J,358.3,49224,2)
 ;;=^5007174
 ;;^UTILITY(U,$J,358.3,49225,0)
 ;;=I35.1^^187^2438^19
 ;;^UTILITY(U,$J,358.3,49225,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49225,1,3,0)
 ;;=3^Nonrheumatic Aortic Vlve Insuff
 ;;^UTILITY(U,$J,358.3,49225,1,4,0)
 ;;=4^I35.1
 ;;^UTILITY(U,$J,358.3,49225,2)
 ;;=^5007175
 ;;^UTILITY(U,$J,358.3,49226,0)
 ;;=I35.2^^187^2438^21
 ;;^UTILITY(U,$J,358.3,49226,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49226,1,3,0)
 ;;=3^Nonrheumatic Aortic Vlve Stenosis w/ Insuff
 ;;^UTILITY(U,$J,358.3,49226,1,4,0)
 ;;=4^I35.2
 ;;^UTILITY(U,$J,358.3,49226,2)
 ;;=^5007176
 ;;^UTILITY(U,$J,358.3,49227,0)
 ;;=I35.9^^187^2438^18
 ;;^UTILITY(U,$J,358.3,49227,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49227,1,3,0)
 ;;=3^Nonrheumatic Aortic Vlve D/O,Unsp
 ;;^UTILITY(U,$J,358.3,49227,1,4,0)
 ;;=4^I35.9
 ;;^UTILITY(U,$J,358.3,49227,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,49228,0)
 ;;=I42.7^^187^2438^3
 ;;^UTILITY(U,$J,358.3,49228,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49228,1,3,0)
 ;;=3^Cardiomyopathy d/t Drug/Extrn Agent
 ;;^UTILITY(U,$J,358.3,49228,1,4,0)
 ;;=4^I42.7
 ;;^UTILITY(U,$J,358.3,49228,2)
 ;;=^5007198
 ;;^UTILITY(U,$J,358.3,49229,0)
 ;;=I21.3^^187^2438^23
 ;;^UTILITY(U,$J,358.3,49229,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49229,1,3,0)
 ;;=3^STEMI,Unspec Site
 ;;^UTILITY(U,$J,358.3,49229,1,4,0)
 ;;=4^I21.3
 ;;^UTILITY(U,$J,358.3,49229,2)
 ;;=^5007087
 ;;^UTILITY(U,$J,358.3,49230,0)
 ;;=I25.5^^187^2438^17
 ;;^UTILITY(U,$J,358.3,49230,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49230,1,3,0)
 ;;=3^Ischemic Cardiomyopathy
